Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Experiences with real-world teclistamab administration in community and outpatient settings: a mixed-methods study of hematology providers.
Journal: Current medical research and opinion
Published: February 18, 2026
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE).
Journal: Hematological oncology
Published: August 27, 2025
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 03, 2024
Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.
Journal: Leukemia & lymphoma
Published: December 05, 2017
Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or Maintained.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 21, 2017
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project.
Journal: Journal of blood medicine
Published: January 29, 2014
Treatment of acute portal vein thrombosis by nontraditional anticoagulation.
Journal: Hepatology (Baltimore, Md.)
Published: September 14, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026